Cargando…
Breast Cancer; Discovery of Novel Diagnostic Biomarkers, Drug Resistance, and Therapeutic Implications
Breast cancer is the second most reported cancer in women with high mortality causing millions of cancer-related deaths annually. Early detection of breast cancer intensifies the struggle towards discovering, developing, and optimizing diagnostic biomarkers that can improve its prognosis and therape...
Autores principales: | Afzal, Samia, Hassan, Muhammad, Ullah, Safi, Abbas, Hazrat, Tawakkal, Farah, Khan, Mohsin Ahmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899313/ https://www.ncbi.nlm.nih.gov/pubmed/35265667 http://dx.doi.org/10.3389/fmolb.2022.783450 |
Ejemplares similares
-
Editorial: Exosomal biomarkers: Roles in diagnostics and therapeutics
por: Gupta, Dwijendra K.
Publicado: (2023) -
Editorial: Breast cancer resistance, biomarkers and therapeutics development in the era of artificial intelligence
por: Khan, Abbas, et al.
Publicado: (2022) -
Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values
por: Dhama, Kuldeep, et al.
Publicado: (2019) -
Biomarker discovery for tuberculosis using metabolomics
por: Yu, Yi, et al.
Publicado: (2023) -
Biomarker discovery in galactosemia: Metabolomics with UPLC/HRMS in dried blood spots
por: Alodaib, Ahmad N., et al.
Publicado: (2023)